These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5895380)

  • 21. [Nephrotic syndrome after treatment with penicillamine in Wilson's disease].
    Hampel R; Meng W; Kallwellis G
    Z Gesamte Inn Med; 1976 Jul; 31(13):507-11. PubMed ID: 960872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term D-penicillamine therapy of Wilson's disease in childhood. Changes in blood coagulation and effects on the haematopoetic system].
    Hayek HW; Schnack H; Widhalm S
    Wien Klin Wochenschr; 1973 Feb; 85(8):122-5. PubMed ID: 4632215
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experiences with penicillamine in Wilson's disease].
    Lössner J; Bachmann H; Eichner B
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():48-53. PubMed ID: 829635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatolenticular degeneration (Wilson's disease).
    Wis Med J; 1970 Mar; 69(3):105-10. PubMed ID: 5434427
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of Wilson's disease.
    Richardson JC
    Mod Treat; 1968 Mar; 5(2):321-31. PubMed ID: 5655947
    [No Abstract]   [Full Text] [Related]  

  • 26. [Wilson's disease (experience of long-term treatment with penicillamine---con penicilamina].
    Escartín Marín P; García Plaza A; Chantar Barrios C
    Rev Clin Esp; 1974 Jun; 133(5):451-4. PubMed ID: 4215106
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of long-term treatment with d-penicillamine on the humoral immune response in patients with Wilson's disease.
    Czlonkowska A
    Mater Med Pol; 1976; 8(1):48-50. PubMed ID: 1263584
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuromuscular transmission and acetylcholine receptor antibodies in penicillamine-treated Wilson's disease patients.
    Anlar B; Kuruoğlu R; Varli K; Topçu M
    Muscle Nerve; 1996 May; 19(5):676-7. PubMed ID: 8618573
    [No Abstract]   [Full Text] [Related]  

  • 29. [Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case].
    López-Guerra N; Alvarez Lario B; García-Moncó C; Peña Sagredo JL
    Med Clin (Barc); 1987 Apr; 88(13):552-4. PubMed ID: 3586738
    [No Abstract]   [Full Text] [Related]  

  • 30. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
    Indaco A; Pellegrino L; Campanella G
    Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
    [No Abstract]   [Full Text] [Related]  

  • 31. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
    Yarze JC
    Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pemphigus in a patient treated with penicillamine for Wilson's disease].
    Degos R; Touraine R; Belaïch S; Revuz J
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):751-3. PubMed ID: 5384189
    [No Abstract]   [Full Text] [Related]  

  • 33. [Recent findings in the therapy of Wilson's disease].
    Rigardetto R; Trevisio A
    Minerva Pediatr; 1975 Feb; 27(3):177-86. PubMed ID: 1226193
    [No Abstract]   [Full Text] [Related]  

  • 34. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 35. [D-penicillamine and cutaneous lesions in Wilson's disease].
    Peiró Grasa A; Barnadas Andiñach M; Moreno Carazo A; Grau-Veciana JM
    Neurologia; 1986; 1(2):88-9. PubMed ID: 2978898
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
    Farinati F; Cardin R; Mestriner C; Sturniolo GC; Naccarato R
    Am J Gastroenterol; 1995 Dec; 90(12):2264-5. PubMed ID: 8540540
    [No Abstract]   [Full Text] [Related]  

  • 37. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of penicillamine on the mental disorders associated with wilson's disease (author's transl)].
    Hach B; Hartung ML
    Nervenarzt; 1979 Feb; 50(2):115-20. PubMed ID: 424037
    [No Abstract]   [Full Text] [Related]  

  • 39. Penicillamine-induced arthropathy in Wilson's disease.
    Walshe JM; Golding DN
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):4-6. PubMed ID: 122670
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurological Wilson's disease.
    McIntyre N
    Q J Med; 1993 May; 86(5):349-50. PubMed ID: 8327653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.